BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 10924990)

  • 1. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Chao C; Erickson B; Fowler J; Gupta N; Martinez A; Thomadsen B;
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):33-48. PubMed ID: 11777620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?
    Petereit DG; Pearcey R
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):359-66. PubMed ID: 10030262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium.
    Nag S; Erickson B; Parikh S; Gupta N; Varia M; Glasgow G
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):779-90. PubMed ID: 11020575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy.
    Lee LJ; Das IJ; Higgins SA; Jhingran A; Small W; Thomadsen B; Viswanathan AN; Wolfson A; Eifel P;
    Brachytherapy; 2012; 11(1):53-7. PubMed ID: 22265438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
    Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R
    Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
    Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.